Creating New Patient-Centered Business Opportunities: From Disease Roadmaps to Innovation Accelerators

Featured Presenter: Dr. Prabir Roy-Chaudhury, MD, PhD, FRCP (Edin), professor of medicine and co-director the UNC Kidney Center

What if we thought about the treatment of diseases as journeys – trips that we could plan for and map out better than we do today? How do we look at the big picture of diseases to identify new business opportunities, plot the most effective treatment courses and arrive at the most viable outcomes?

Join us at the next Carolina Innovation Seminar to hear Dr. Prabir Roy-Chaudhury, professor of medicine and co-director of the UNC Kidney Center, describe the translational research program he leads in uremic vascular biology. Find out how he worked with a multi-disciplinary team to develop a roadmap for kidney disease and also participated in an innovation accelerator in order to help spark new technology opportunities, business building and better patient outcomes targeting kidney diseases.

Dr. Roy-Chaudhury will describe lessons learned as the founding co-chair of the Kidney Health Initiative, which is a public-private partnership between the American Society of Nephrology and the FDA. He is also as a current member of the KidneyX Steering Committee (which is a kidney innovation accelerator). Both organizations aim to bring together nephrologists, industry partners patient advocacy groups, investors and regulatory agencies to facilitate the passage of drugs, devices and biologics into the kidney disease space.

During the seminar, you’ll learn:

• What is the scale of kidney disease – and why is there a great opportunity for patient-centered innovation in this area?
• How does building a disease roadmap help bring focus to unmet needs and new opportunities for therapies, businesses and technologies?
• How can public-private partnerships create a synergy that serves researchers, industry leaders and patients?
• How can the idea of disease roadmaps inform your own translational and entrepreneurial work?

About Dr. Prabir Roy-Chaudhury

Dr. Roy-Chaudhury currently leads a translational research program in uremic vascular biology funded through the National Institutes of Health, the Veterans Administration research program, and through industry grants. He has published over 175 papers, and is a sought after invited speaker, both nationally and internationally.

He has also been actively involved in the public policy and administrative aspects of dialysis vascular access care and hemodialysis as a previous or current board member/counselor/committee chair for the American Society of Diagnostic and Interventional Nephrology, the Renal Network, the Interventional Nephrology Advisory Group of the American Society of Nephrology (ASN), the ASN Board of Advisors and Capitol Hill advocacy team, the ASN Post Graduation Education Committee and the International Society of Nephrology-India and South Asia Committees, as well as being the previous President of the American Nephrologists of Indian Origin (ANIO).

Dr. Roy-Chaudhury was also the founding American Society of Nephrology co-chair of the Kidney Health Initiative, which is a public-private partnership between the ASN and the FDA, which aims to bring together nephrologists, industry partners, patient advocacy groups and regulatory agencies; in an attempt to facilitate the passage of drugs, devices, and biologics into the kidney disease space. In 2019, he was elected to the ASN Council which is a nine-member apex leadership body for the American Society of Nephrology which has over 18,000 members.

RSVP: https://www.eventbrite.com/e/creating-new-patient-centered-business-opportunities-from-disease-roadmaps-to-innovation-tickets-91552246233?utm-medium=discovery&utm-campaign=social&utm-content=attendeeshare&aff=escb&utm-source=cp&utm-term=listing